Haleon PLC Logo

Haleon PLC

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+1 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Haleon PLC is a global leader in consumer healthcare, operating as a pure-play business dedicated to improving everyday health. Formerly the consumer healthcare division of GSK, the company's portfolio comprises a wide range of category-leading, over-the-counter (OTC) brands. Its core product areas include oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Key brands under its management include Sensodyne, Panadol, Advil, Voltaren, and Centrum. With a global presence, Haleon focuses on delivering science-backed and trusted health products directly to consumers worldwide.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Haleon PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-21 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-20 14:20
Major Shareholding Notification
Holding(s) in Company
English 38.6 KB
2025-08-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.2 KB
2025-08-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-14 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-13 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-12 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-11 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-08 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-07 17:00
Major Shareholding Notification
Holding(s) in Company
English 38.5 KB
2025-08-07 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-06 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-08-05 10:15
Director's Dealing
Director/PDMR Shareholding
English 37.5 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Global pharmaceutical company creating innovative treatments for brain diseases.
Denmark HLUN
Hong Kong N/A
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL
Idorsia Ltd Logo
Develops novel medicines for CNS, cardiovascular, immunological, and orphan diseases.
Switzerland IDIA
Immuno-Biological Laboratories Co., Ltd. Logo Japan 4570
Indivior PLC Logo
A global pharmaceutical firm developing treatments for addiction and mental illness.
United Kingdom INDV
Infant Bacterial Therapeutics Logo
Developing microbiome therapies for premature infants to prevent life-threatening intestinal disease.
Sweden IBT
Intercure Ltd. Logo
Producer of pharma-grade, GMP-certified medical cannabis products for patients outside North America.
Israel INCR
Intervacc AB Logo
Develops recombinant protein vaccines for animal health, led by its vaccine for equine strangles.
Sweden IVACC
Ipsen Logo
Develops transformative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN